Skip to main content
Premium Trial:

Request an Annual Quote

GeneArt Debuts Online Tool to Design, Order 'Low-Price' Synthetic Genes

NEW YORK (GenomeWeb News) — German synthetic genetics company GeneArt will now sell custom genes via an online platform that will allow customers in the “low-price market” to design and order synthetic genes, the company said today.
The company said its Mr. Gene tool allows customers to design the genes in a “do-it-yourself” procedure or through a software-assisted procedure. “The new platform gives scientists with small budgets easier access to synthetic genes,” the company said in a statement.
GeneArt CFO Christian Ehl said the company launched the service after anticipating strong sales growth in the synthetic genes market. Ehl said the company projects the new service will contribute 25 percent to GeneArt’s sales in the medium term.
The company said it expects Mr. Gene to be well suited for the academic market because it offers a low price, but it did not disclose pricing details.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more